Drugdu.com Launches Digital Marketing Strategy Solution
Drugdu.com Launches Digital Marketing Strategy Solution for Pharmaceuticals and
Medical Devices at CMEF Shanghai 2018
Drugdu.com presents their digital marketing strategy for the pharmaceutical and medical device industry and launches the Ddu Trade Accelerator to assist suppliers in expanding international business opportunities.
Drugdu.com (Ddu), the leading global pharmaceutical and medical device B2B online platform, attended the CMEF exhibition in Shanghai and showcased their new “Internet + cross-border medical trade” marketing model. At the same time, a symposium for the Ddu Trade Accelerator was held to share insight on new methods of taking advantage of online promotions to open up international markets and accelerate cross-border trade. The conference was very successful, locking the attention of people present and opening up opportunities for the sharing of ideas and re-thinking of marketing strategies.
According to statistics, the global medical device market was estimated to be worth 406.3 billion USD in 2016, and is expected to exceed 477.5 billion USD by 2020. With the domestic market gradually becoming more saturated, more and more medical device suppliers are paving their way to explore international markets.
However, the promotion of medical devices is beset with difficulties and the best medical device marketing strategy is to offer top quality products and client services along with proper promotional material that enables clients to acquire product information in a faster and more accurate way. For buyers, finding products through traditional channels often results in nothing or incomplete information due to variations of medical devices and scattered information. And for suppliers, visiting clients and attending exhibitions may not always be cost-effective.
In order to improve the efficiency of international promotions of medical devices, Ddu launched the Ddu Trade Accelerator, a one-stop online promotion service, a product of many years of in-depth experience in the fields of pharmaceutical drugs and medical devices, aiming to assist pharmaceutical and medical device companies develop global target markets and acquire clients by promoting their quality products through comprehensive marketing strategies such as accurate orientations, creative strategies, effective data monitoring, data analyses and diagnostic optimization.
In response to the difficulties regarding international promotions of medical devices, here are 4 breakthroughs of the Ddu Trade Accelerator:
1.Efficient promotions
Promotions through high quality channels locally and abroad to accurately cover the main medical market.
2.Brand advertisements
AAAA-class standards for advertising productions with tailor-made advertisements for the promotion of medical devices.
3. Data orientation
Full-time and real-time data presentations and flexible adjustments of marketing strategies.
4.Professional management
BAT-level technical team and evasion of sensitive policies
According to the management of Ddu, the Ddu Trade Accelerator was developed by a professional team with ten years’ experience to provide tailor-made advertisement promotions for medical device companies. Ddu is also in cooperation with SGS, an internationally authorized institution, and various media giants to conduct promotions on social media platforms and content marketing for maximized exposure.
Since its launch in October 2017, the Ddu Trade Accelerator has served about 100 medical companies covering 36 countries and regions and attracted the attention of over 400,000 people engaged in medical trade. Additionally, all participating surgical instrument companies received an average of 195 inquiries and were exposed to 26,000 people in South Asia. Medical consumables companies were also pleased with the results since they received an average of 128 inquiries and were exposed to 11,000 people in North America.
About Drugdu.com (Ddu)
Drugdu.com (Ddu) is the leading global B2B online platform focused on the cross-border trade of pharmaceuticals and medical devices.
As a pioneer in the industry, Ddu's advanced technology and user-centered services is aimed at not only accelerating the circulation of pharmaceuticals and medical devices around the world, but also simplifying industry trading, making it more practical and efficient.
Our expertise in the international medical trade industry has enabled Ddu to provide a full range of solutions for over 100,000 global suppliers and buyers, helping them build and develop channels of communication and expand international business opportunities.
For more information about Drugdu.com (Ddu), visit our website at http://www.drugdu.com/ or follow us on Facebook, LinkedIn, Twitter, YouTube and Google Plus.
About Ddu Trade Accelerator
The Ddu Trade Accelerator is a one-stop online promotion service, aiming to assist pharmaceutical and medical device companies in developing global target markets and acquire clients by promoting their quality products through comprehensive marketing strategies.
For more information about the Ddu Trade Accelerator, please visit
http://act.drugdu.com/DDU-Trade-Accelerator-EN-943015866921857024.html
or contact Drugdu.com at marketing(at)drugdu(dot)com
Read the full story at https://www.prweb.com/releases/2018/05/prweb15458149.htm
2026-09-15
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China Beauty Duke Fined RMB 210,000 For Misleading Cosmetic Product Promotion
-
BASF Reports Modest Third Quarter Decline Amid Global Market Caution
-
Evonik Launches Advanced Gas-Phase Alumina Plant in Japan
-
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
Evonik Achieves Successful Trial Production at Shanghai Polyamide Plant
-
BASF Partners with Andritz for Carbon Capture Project in Aarhus
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
LANXESS Expands Rubber Additives Production at Qingdao Plant
-
BASF Plans IPO for Agricultural Solutions Business
Recommend Reading
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
-
Croda’s First-Half Profit Outpaces Sales as Beauty Actives Grow 19%
-
GACL Approves Additional Hydrochloric Acid Unit at Dahej
-
January ammonium sulfate market trend in China shows a strong increase
-
Raw Materials Soften, Consumption Sluggish—PC Prices Fall from High Levels
-
Winter Storms Combined with Geopolitical Tensions Drive Oil Prices Up 3% in a Single Day
-
Market Support Weakens, Acetic Acid Prices Continuously Decline
-
January China MIBK Market Shows a Phased Recovery
- Hot Searches
- reta where to buy
- johnson matthey catalysts
- naphtha prices
- reta peptide buy
- best places to buy retatrutide
- choline chloride sds
- sodium acetate sds
- where to buy anhydrous ammonia
- retatrutide supplier china
- diethylenetriamine sds
- piperazine
- sodium potassium mag sulfates 17.5 gram-3.13 gram-1.6 gram oral solution